Incyte to Report Fourth Quarter and Year-End Financial Results
Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year end 2017 financial results
conference call and webcast for 10:00 a.m. ET on Thursday, February 15, 2018.
The schedule for the press release and conference call/webcast is as follows:
|
|
|
|
|
|
|
• Q4 & YE 2017 Press Release:
|
|
|
|
|
February 15, 2018 at 7:00 a.m. ET |
|
• Q4 & YE 2017 Conference Call:
|
|
|
|
|
February 15, 2018 at 10:00 a.m. ET |
|
• Domestic Dial-In Number:
|
|
|
|
|
877-407-3042 |
|
• International Dial-In Number:
|
|
|
|
|
201-389-0864 |
|
• Conference ID Number:
|
|
|
|
|
13675376 |
|
|
|
|
|
|
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need
the conference ID number 13675376.
The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and
commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
Incyte Corporation
Investors
Michael Booth, DPhil, +1 302-498-5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20180124005007/en/